ACAD
38.36
0.00
N/A%
AEMD
0.196
0.00
N/A%
APRI
1.61
0.00
N/A%
ARNA
4.49
0.00
N/A%
ATEC
1.41
0.00
N/A%
CNAT
6.66
0.00
N/A%
CRXM
0.354
0.00
N/A%
CYTX
0.985
0.00
N/A%
DXCM
69.43
0.00
N/A%
GNMK
10.69
0.00
N/A%
HALO
16.86
0.00
N/A%
ILMN
189.59
0.00
N/A%
INNV
0.145
0.00
N/A%
INO
10.35
0.00
N/A%
ISCO
0.074
0.00
N/A%
ISIS
66.37
-1.38
-2.03%
LGND
89.75
0.00
0.00%
LPTN
2.23
0.00
N/A%
MBVX
3.36
0.00
N/A%
MEIP
2.16
0.00
N/A%
MNOV
4.09
0.00
N/A%
MRTX
27.87
0.00
N/A%
MSTX
0.49
0.00
0.00%
NBIX
43.37
-0.31
-0.71%
NUVA
43.99
0.00
N/A%
ONCS
0.268
0.00
N/A%
ONVO
5.19
0.00
N/A%
OREX
7.36
0.00
N/A%
OTIC
31.8
0.00
N/A%
QDEL
23.38
0.00
N/A%
RCPT
169.885
-1.255
-0.733%
RGLS
17.49
0.00
N/A%
RMD
65.7
0.00
N/A%
SCIE
0.026
0.00
N/A%
SPHS
0.8
0.00
N/A%
SRNE
10.52
0.00
N/A%
TROV
8.8
0.00
0.00%
VICL
1.005
0.00
N/A%
VOLC
17.99
0.00
N/A%
ZGNX
1.54
0.00
N/A%
ACAD
38.36
0.00
N/A%
AEMD
0.196
0.00
N/A%
APRI
1.61
0.00
N/A%
ARNA
4.49
0.00
N/A%
ATEC
1.41
0.00
N/A%
CNAT
6.66
0.00
N/A%
CRXM
0.354
0.00
N/A%
CYTX
0.985
0.00
N/A%
DXCM
69.43
0.00
N/A%
GNMK
10.69
0.00
N/A%
HALO
16.86
0.00
N/A%
ILMN
189.59
0.00
N/A%
INNV
0.145
0.00
N/A%
INO
10.35
0.00
N/A%
ISCO
0.074
0.00
N/A%
ISIS
66.37
-1.38
-2.03%
LGND
89.75
0.00
0.00%
LPTN
2.23
0.00
N/A%
MBVX
3.36
0.00
N/A%
MEIP
2.16
0.00
N/A%
MNOV
4.09
0.00
N/A%
MRTX
27.87
0.00
N/A%
MSTX
0.49
0.00
0.00%
NBIX
43.37
-0.31
-0.71%
NUVA
43.99
0.00
N/A%
ONCS
0.268
0.00
N/A%
ONVO
5.19
0.00
N/A%
OREX
7.36
0.00
N/A%
OTIC
31.8
0.00
N/A%
QDEL
23.38
0.00
N/A%
RCPT
169.885
-1.255
-0.733%
RGLS
17.49
0.00
N/A%
RMD
65.7
0.00
N/A%
SCIE
0.026
0.00
N/A%
SPHS
0.8
0.00
N/A%
SRNE
10.52
0.00
N/A%
TROV
8.8
0.00
0.00%
VICL
1.005
0.00
N/A%
VOLC
17.99
0.00
N/A%
ZGNX
1.54
0.00
N/A%
Home » Archive by Category

Syndication

GlycoRegImmune Raises $4.38 Million in Equity Financing

April 21, 2015 – 11:03 am

GlycoRegImmune Inc. (GRI Bio), a biotech developing treatments for inflammatory disease, recently raised $4.38 million in equity financing, according to a recent regulatory filing.

Pancreatic cancer breakthrough: scientists turn cancer cells into normal cells

April 21, 2015 – 10:55 am

Researchers have found a novel avenue for therapeutic intervention of pancreatic cancer – the “silent cancer.”

Discovery of new role of SOX2 protein sheds light on neurogenesis in the adult brain

April 21, 2015 – 10:48 am

Sanford-Burnham researchers recently discovered a key role of a protein called SOX2 in neuronal development. SOX2 promotes the activation of genes involved in differentiation, enabling neural progenitor cells to turn into mature neurons in the brains o…

Protecting pancreatic cells from stress could hold promise for treating diabetes

April 21, 2015 – 10:24 am

New research shows that antioxidants may improve beta cell functions and glucose metabolism in type 2 diabetes.

Research Scientist/Associate

April 21, 2015 – 10:21 am

CA-San Diego, Research Scientist/Associate Chemtron Biotech is seeking a Research Scientist/Associate with strong interpersonal communication skills to lead a R&D team through the product development cycle of IVD tests for market.​ The Research Scientist/Associate will be responsible for the development of immunoassay tests in the drugs of abuse field for FDA submission and clearance. This position reports to t

CALL CENTER / SALES – Recent College Grads Welcome: $35,000-$70,000/yr (San Diego)

April 21, 2015 – 10:21 am

Fast growing web marketing company that provides websites, social media, SEO and paid search solutions to the businesses throughout the country is seeking a Sales Representative to contact prospective clients and schedule online appointments for a de […

Sales/Marketing Associate

April 21, 2015 – 10:19 am

CA-San Diego, Marketing/Sales Associate Chemtron Biotech is a manufacturing based company for IVD rapid tests and are currently looking to expand our sales and marketing efforts to increase our brand name and international reach. We are looking for a c…

Buyer/Planner, Medical Device/Biotech experience required – Agena Bioscience – San Diego, CA

April 21, 2015 – 8:21 am

Maintains a master MRP schedule to support production and development. GMP and ISO standards relating to materials….
From Indeed – 21 Apr 2015 15:21:54 GMT
– View all San Diego jobs

No autism-vaccine link, study finds

April 21, 2015 – 8:00 am

New study finds no link between autism and MMR vaccination, even in high-risk children.

Invivoscribe(R) lanza cuatro ensayos LimphoTrack(R) Dx basados en NGS con marca CE

April 21, 2015 – 7:02 am

SAN DIEGO, CA–(Marketwired – Apr 21, 2015) –
Invivoscribe Technologies, Inc. (IVS) anunció hoy el lanzamiento comercial de cuatro ensayos de secuenciación de próxima generación (NGS) LymphoTrack(R) Dx, con marca CE, utilizados para detectar el receptor de células T gamma (TRG) y los reordenamientos de los genes de las cadenas pesadas de las inmunoglobulinas (IGH). Estos kits de pruebas de diagnóstico in vitro (IVD), validados para su uso con los instrumentos Illumina MiSeq(R) y ThermoFisher Ion PGM(TM), comprenden solo algunos de los ensayos LymphoTrack Dx con marca CE que Invivoscribe intenta lanzar este año.